A Quantitative Point-of-Need Assay for the Assessment of Vitamin D3 Deficiency.
S VemulapatiElizabeth G ReyD O'DellSaurabh MehtaD EricksonPublished in: Scientific reports (2017)
Vitamin D is necessary for the healthy growth and development of bone and muscle. Vitamin D deficiency, which is present in 42% of the US population, is often undiagnosed as symptoms may not manifest for several years and long-term deficiency has been linked to osteoporosis, diabetes and cancer. Currently the majority of vitamin D testing is performed in large-scale commercial laboratories which have high operational costs and long times-to-result. Development of a low-cost point-of-need assay could be transformative to deficiency analysis in limited-resource settings. The best biomarker of vitamin D status, 25hydroxyvitamin D3 (25(OH)D3), however, is particularly challenging to measure in such a format due to complexities involved in sample preparation, including the need to separate the marker from its binding protein. Here we present a rapid diagnostic test for the accurate, quantitative assessment of 25(OH)D3 in finger-stick blood. The assay is accompanied by a smartphone-assisted portable imaging device that can autonomously perform the necessary image processing. To achieve accurate quantification of 25(OH)D3, we also demonstrate a novel elution buffer that separates 25(OH)D3 from its binding protein in situ, eliminating the need for sample preparation. In human trials, the accuracy of our platform is 90.5%.
Keyphrases
- binding protein
- low cost
- high throughput
- high resolution
- bone mineral density
- endothelial cells
- type diabetes
- postmenopausal women
- cardiovascular disease
- papillary thyroid
- skeletal muscle
- molecularly imprinted
- deep learning
- replacement therapy
- single cell
- mass spectrometry
- induced pluripotent stem cells
- sleep quality
- squamous cell
- soft tissue
- adipose tissue
- childhood cancer
- weight loss
- bone loss
- loop mediated isothermal amplification